Navigation Links
PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
Date:10/29/2008

PharmaSmart International, Inc., an award winning "Top 100" Rochester NY Growth Company, boasts premiere pharmacy services innovation.

Rochester, NY (PRWEB) October 29, 2008 -- PharmaSmart International, an innovative health management company who advances patient blood pressure management at Retail Pharmacy levels, worksites, medical facilities and specialty care centers boasts an impressive track record as one of the "Top 100" high growth firms in Rochester, NY. A closer look at their progress shows that this is just the tip of the iceberg. Having secured over 75% penetration in the Canadian retail pharmacy marketplace, PharmaSmart executives are now turning their focus to the US pharmacy market. The company's emerging US division, PharmaSmart USA, has positioned itself at the heart of new growth opportunity - pharmacy services and disease state management.



PharmaSmart's value proposition is capturing the attention of leading US pharmacy regional and national chains as well as traditional community pharmacy. Unlike existing blood pressure programs which may primarily act as vehicles for 3rd party advertising, PharmaSmart proposes to convert the hypertensive patient (100 million Americans) into a unique revenue opportunity, and retain that consumer with an exclusive, pharmacy branded BP management program. This service oriented approach addresses the need for today's pharmacy to generate a combined ROI and patient loyalty through innovative pharmacy service programs.

The company is defining itself as a health care component supported by secondary opportunities such as Health & Wellness cooperative partnerships. Its technology features multiple messaging channels attractive to leading health care sponsors looking to reac
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information
2. China Yingxia International, Inc. to Promote Benefits of Its Soy Milk Products Over Scandal-Stricken Cows Milk in China
3. Block Imaging International, Inc. Partners with Dicom Solutions, Inc. to Offer New Products
4. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
5. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
6. WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air
7. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
8. Chindex International, Inc. Announces CDC Contract Signing
9. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
10. DATATRAK International, Inc. Receives Notice From Nasdaq
11. China Yingxia International, Inc. Appoints Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
(Date:5/19/2013)... (PRWEB) May 19, 2013 Farming methods ... seed in the ground 10,000 years ago. Most recently, ... farm productivity by using genetically engineered seeds and by ... seeing a backlash to these techniques due to the ... chemicals and a corresponding surge in interest in organic, ...
(Date:5/19/2013)... Angeles (PRWEB) May 19, 2013 Yeast infections ... can appear in sensitive areas of the human body. A ... Yeastrol. This new formula provides a unique method of application ... new spray solution is now provided to men and women ... is naturally absorbed in the body through food and is ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Beginning Wednesday, May ... Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" and ... RRVBC will provide hot dogs and all the fixin's ... slushies each day throughout the summer. “Donors are our lifeline. ... a stable and adequate blood supply. This is a ...
(Date:5/19/2013)... fender benders and serious car accidents are common sights ... to respond appropriately to the situation. According to ... 2010, accidents, including car accidents, are the fifth leading ... automobile accident-related deaths cost over $70 billion ... and passengers receive treatment in an emergency room every ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
Breaking Medicine News(10 mins):Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2
... Two methods that permit scientists to examine ... months release of Cold Spring Harbor Protocols . ... www.cshprotocols.org ), describe how to fluorescently tag cells in ... sophisticated imaging methods, permit scientists to visualize even subtle ...
... Splash with Las Vegas and Tucson Marathon Runners, ... ibuprofen,before an event to prevent inflammation and pain, but ... studies by researchers at,Appalachian State University and Vanderbilt University, ... that taking ibuprofen,before exercise may be unhealthy in the ...
... 3 As momentum continues to,build on the ... in Medicare, the Pharmaceutical Care Management Association,(PCMA) today ... J. Lyle,Bootman, Ph.D., Sc.D., Last year, Dr. ... recommended that all physicians begin using e-prescribing by,2010 ...
... Home Front Needs of Families with Deployed Service Members ... ... Alliance will present $15,000 to the Missouri National Guard -,Missouri Military Family Relief ... and their families., Don Brown, market vice president for the central market ...
... HUNTSVILLE, Ala., Dec. 3 Operon,Biotechnologies, Eurofins MWG ... Genomics network - announced today that they have ... new worldwide leader in the competitive,custom oligonucleotide market. ... of,the art high-throughput production facilities in all major ...
... and CEO retires; Mike Gallagher, President and ... MIAMI, Dec. 3 AvMed Health Plans ... announced plans to retire December 31,2007. As a ... parent company,SantaFe HealthCare, who already has overall leadership ...
Cached Medicine News:Health News:Cold Spring Harbor Protocols features innovative methods for embryology research 2Health News:Marathoners Share Tom Brady and LaDainian Tomlinson Pain Relief Affinity 2Health News:TriWest Contributes $15,000 to Missouri National Guard Fund 2Health News:MWG and Operon Are Joining Forces 2Health News:AvMed Announces Senior Leadership Changes 2
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... Scientific,Corporation (NYSE: BSX ) today announced ... press announcements at the Cardiovascular Research Foundation,s,(CRF) ... which runs from October 20 to 25 ... be announcing a wide range of safety ...
... the novel,selective relaxant binding agent (SRBA) being developed ... neuromuscular blockade as,compared to neostigmine in the Phase ... Spectrum, faster recovery from profound neuromuscular,blockade compared to ... were presented today at the 2007 annual meeting ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 2Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 3Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 4Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 5
Inquire...
Inquire...
Inquire...
Inquire...
Medicine Products: